|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
*
From the College of Public Health (Drs. Enright and Lebowitz), University of Arizona, Tuscon, AZ; the Department of Biostatistics and Epidemiology (Ms. McClelland), the Mayo Clinic, Rochester, NY; and the Department of Pulmonary and Critical Care Medicine (Dr. Buist), Oregon Health Sciences University, Portland, OR.
A list of participants is shown in the Appendix.
Correspondence to: Paul L. Enright, MD, The University of Arizona, 1501 North Campbell Ave, Tucson, AZ 85724; e-mail: lungguy{at}aol.com
Objective: To determine the correlates of the lability of peak expiratory flow (PEF) in the elderly.
Methods:
A community sample of 4,581 persons
65 years old from the
Cardiovascular Health Study completed an asthma questionnaire and
underwent spirometry. During a follow-up examination of the cohort,
1,836 persons agreed to measure PEF at home twice daily for 2 weeks,
and 90% successfully obtained at least 4 days of valid measurements.
PEF lability was calculated as the highest daily (PEF maximum - PEF
minimum)/mean PEF.
Results: Mean PEF measured at home was accurate when compared to PEF determined by spirometry in the clinic. Mean PEF lability was 18% in those with current asthma (n = 165) vs 12% in healthy nonsmokers (upper limit of normal, 29%). Approximately 26% of those with asthma and 14% of the other participants had abnormally high PEF lability (> 29%). After excluding participants with asthma, other independent predictors of high PEF lability included black race, current and former smoking, airway obstruction on spirometry, daytime sleepiness, recent wheezing, chronic cough, emphysema, and wheezing from lying in a supine position. Despite having a lower mean PEF, those reporting congestive heart failure (n = 82) did not have significantly higher PEF lability.
Conclusions: Measurement of PEF lability at home is highly
successful in elderly persons. PEF lability
30% is abnormal in the
elderly and is associated with asthma.
Key Words: airway lability asthma elderly peak expiratory flow
This article has been cited by other articles:
![]() |
M.R. Abraham, L. J. Olson, M. J. Joyner, S. T. Turner, K. C. Beck, and B. D. Johnson Angiotensin-Converting Enzyme Genotype Modulates Pulmonary Function and Exercise Capacity in Treated Patients With Congestive Stable Heart Failure Circulation, October 1, 2002; 106(14): 1794 - 1799. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |